xCures(@xcures_platform) 's Twitter Profile Photo

Targeted treatments for unique patients.

Watch the full video with David Hysong and Katherine Arline from SHEPHERD Health on YouTube: youtu.be/XZ9xtByAhxU

account_circle
Precede Biosciences(@Precede_Bio) 's Twitter Profile Photo

We are excited to announce that two abstracts for Precede Biosciences's comprehensive epigenomic liquid biopsy platform have been selected for presentation at , taking place from May 31-June 4, 2024 in Chicago.

We are excited to announce that two abstracts for @Precede_Bio's comprehensive epigenomic liquid biopsy platform have been selected for presentation at #ASCO24, taking place from May 31-June 4, 2024 in Chicago. #PrecisionMedicine #PrecisionOncology #Healthcare #DrugDevelopment…
account_circle
LARVOL(@Larvol) 's Twitter Profile Photo

Keep up with the newest developments in !

LARVOL curates top news, carefully assessed for uniqueness, relevance, and impact by our industry experts. Schedule your demo today 👉 bit.ly/3goXLHE

account_circle
ACS Publications Bio & Med Chem Content(@ACSBioMed) 's Twitter Profile Photo

Akt inhibitor Capivasertib's FDA nod marks precision therapy advance. Paves way for selective treatments with CAAIs!

Read now in ➡ go.acs.org/985

Akt inhibitor Capivasertib's FDA nod marks precision therapy advance. Paves way for selective treatments with CAAIs! #PrecisionOncology 

Read now in #JMedChem ➡ go.acs.org/985
account_circle
AITech365(@AITech365) 's Twitter Profile Photo

New Study Shows Veracyte, Inc.’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance

aitech365.com/healthcare/lif…

New Study Shows @Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance

aitech365.com/healthcare/lif…

#AITech365 #cancerdiagnostics #LifeScience #news #precisiononcology #Veracyte
account_circle